Combining clinical safety* and ease-of-use, the Cordis EXOSEAL™ Vascular Closure Device means a more confident close and improved patient outcomes.
- Easy-to-Use Functionality
- Trusted Bioabsorbable Technology
- Precise Extravascular Closure
- Excellent Clinical Results*
* Clinical data from the ‘ECLIPSE Trial’ indicates safety in terms of vascular injury, access site-related bleeding, infection or nerve injury, new ipsilateral lower extremity ischemia or SAE. Wong et al JACC Cardiovasc Interv. 2009 Aug;2(8):785-93.